In this issue:
COVID-19 outcomes in patients with cancer
One-time endoscopic screening significantly reduces esophageal cancer incidence and mortality
Afatinib may be an option for TP53 and/or EGFR-mutated platinum-refractory esophageal cancer
A sustained counselling and free medication program aids smoking abstinence in cancer patients
KEYNOTE-062 reveals a place for pembrolizumab in front-line gastric cancer therapy
Tumour mutational burden drives response to pembrolizumab in advanced solid tumours
CONKO-006 assesses gemcitabine plus sorafenib in patients with R1 resection of pancreatic cancer
Adjuvant CRT confers a survival benefit for patients with positive margins after pancreatic cancer resection
Veliparib plus FOLFOX shows promise in platinumnaïve, mutated metastatic pancreatic cancer
ALPINE trial of ipafricept with gemcitabine and nab-paclitaxel for metastatic PDAC terminated early
Please login below to download this issue (PDF)